Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies
- 1 May 2019
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 7 (5) , 773-783
Abstract
Tumors are inherently heterogeneous in antigen expression, and escape from immune surveillance due to antigen loss remains one of the limitations of targeted immunotherapy. Despite the clinical use of adoptive therapy with chimeric antigen receptor (CAR)–redirected T cells in lymphoblastic leukemia, treatment failure due to epitope loss occurs. Targeting multiple tumor-associated antigens (TAAs) may thus improve the outcome of CAR-T cell therapies. CARs developed to simultaneously target multiple targets are limited by the large size of each single-chain variable fragment and compromised protein folding when several single chains are linearly assembled. Here, we describe single-domain antibody mimics that function within CAR parameters but form a very compact structure. We show that antibody mimics targeting EGFR and HER2 of the ErbB receptor tyrosine kinase family can be assembled into receptor molecules, which we call antibody mimic receptors (amR). These amR can redirect T cells to recognize two different epitopes of the same antigen or two different TAAs in vitro and in vivo.Keywords
All Related Versions
Funding Information
- NCI (R01CA157738)
- NCI (R01-CA193140-03)
This publication has 31 references indexed in Scilit:
- Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7Molecular Therapy, 2009
- Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage DisplayJournal of Molecular Biology, 2008
- Alternative binding proteins: Affibody binding proteins developed from a small three‐helix bundle scaffoldThe FEBS Journal, 2008
- Directed Evolution to Low Nanomolar Affinity of a Tumor-Targeting Epidermal Growth Factor Receptor-Binding Affibody MoleculeJournal of Molecular Biology, 2008
- High-throughput Generation of Synthetic Antibodies from Highly Functional Minimalist Phage-displayed LibrariesJournal of Molecular Biology, 2007
- Selection and Characterization of Her2 Binding-designed Ankyrin Repeat ProteinsJournal of Biological Chemistry, 2006
- Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody MoleculeCancer Research, 2006
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Engineered proteins as specific binding reagentsCurrent Opinion in Biotechnology, 2005
- Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosisBlood, 2005